| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1141 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 604 | 2022 |
| Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: an insight from structural data A Khan, T Zia, M Suleman, T Khan, SS Ali, AA Abbasi, A Mohammad, ... Journal of cellular physiology 236 (10), 7045-7057, 2021 | 361 | 2021 |
| Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study MT Khan, A Ali, Q Wang, M Irfan, A Khan, MT Zeb, YJ Zhang, ... Journal of Biomolecular Structure and Dynamics 39 (10), 3627-3637, 2021 | 158 | 2021 |
| Immunoinformatics approaches to explore Helicobacter Pylori proteome (Virulence Factors) to design B and T cell multi-epitope subunit vaccine M Khan, S Khan, A Ali, H Akbar, AM Sayaf, A Khan, DQ Wei Scientific reports 9 (1), 13321, 2019 | 141 | 2019 |
| Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion … MTJ Quimque, KIR Notarte, RAT Fernandez, MAO Mendoza, RAD Liman, ... Journal of Biomolecular Structure and Dynamics 39 (12), 4316-4333, 2021 | 130 | 2021 |
| In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro) A Khan, W Heng, Y Wang, J Qiu, X Wei, S Peng, S Saleem, M Khan, ... Phytotherapy Research 35 (6), 2841, 2021 | 111 | 2021 |
| Immunoinformatics and structural vaccinology driven prediction of multi-epitope vaccine against Mayaro virus and validation through in-silico expression S Khan, A Khan, AU Rehman, I Ahmad, S Ullah, AA Khan, SS Ali, ... Infection, Genetics and Evolution 73, 390-400, 2019 | 106 | 2019 |
| Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro) A Khan, SS Ali, MT Khan, S Saleem, A Ali, M Suleman, Z Babar, A Shafiq, ... Journal of Biomolecular Structure and Dynamics 39 (13), 4659-4670, 2021 | 105 | 2021 |
| Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches MT ul Qamar, S Ahmad, I Fatima, F Ahmad, F Shahid, A Naz, SW Abbasi, ... Computers in Biology and Medicine 132, 104389, 2021 | 100 | 2021 |
| Phylogenetic analysis and structural perspectives of RNA-dependent RNA-polymerase inhibition from SARs-CoV-2 with natural products A Khan, M Khan, S Saleem, Z Babar, A Ali, AA Khan, Z Sardar, ... Interdisciplinary Sciences: Computational Life Sciences 12, 335-348, 2020 | 96 | 2020 |
| Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein A Khan, MT Khan, S Saleem, M Junaid, A Ali, SS Ali, M Khan, DQ Wei Computational and structural biotechnology journal 18, 2174-2184, 2020 | 96 | 2020 |
| Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems … A Khan, M Junaid, AC Kaushik, A Ali, SS Ali, A Mehmood, DQ Wei PloS one 13 (5), e0196484, 2018 | 91 | 2018 |
| The Omicron (B. 1.1. 529) variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data A Khan, H Waris, M Rafique, M Suleman, A Mohammad, SS Ali, T Khan, ... International journal of biological macromolecules 200, 438-448, 2022 | 81 | 2022 |
| Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune … A Khan, S Khan, S Saleem, N Nizam-Uddin, A Mohammad, T Khan, ... Computers in Biology and Medicine 133, 104420, 2021 | 78 | 2021 |
| Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein–Barr virus (EBV) A Ali, A Khan, AC Kaushik, Y Wang, SS Ali, M Junaid, S Saleem, ... Scientific reports 9 (1), 720, 2019 | 72 | 2019 |
| Network pharmacology: exploring the resources and methodologies J Muhammad, A Khan, A Ali, L Fang, W Yanjing, Q Xu, DQ Wei Current topics in medicinal chemistry 18 (12), 949-964, 2018 | 72 | 2018 |
| SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines A Khan, T Khan, S Ali, S Aftab, Y Wang, W Qiankun, M Khan, M Suleman, ... Biomedicine & Pharmacotherapy 143, 112176, 2021 | 71 | 2021 |
| Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance MT Khan, A Khan, AU Rehman, Y Wang, K Akhtar, SI Malik, DQ Wei Scientific Reports 9 (1), 7482, 2019 | 71 | 2019 |
| The SARS-CoV-2 B. 1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective A Khan, J Gui, W Ahmad, I Haq, M Shahid, AA Khan, A Shah, A Khan, ... RSC advances 11 (48), 30132-30147, 2021 | 63 | 2021 |
Dongqing WeiProfessor of Bioinformatics/Computational Physics/Chemistry, Shanghai Jiaotong UniversityVerified email at sjtu.edu.cn
